Form 4: Align Tech Exec Coletti Reports Stock Transactions

Align Technology's EVP, Chief Legal & Regulatory, Julie Ann Coletti, reported various acquisitions and dispositions of common stock and derivative securities, primarily related to equity compensation vesting.

Summary

• Julie Ann Coletti, EVP, Chief Legal & Regulatory of Align Technology, Inc. (ALGN), reported multiple transactions involving company stock and derivative securities.
• On February 20, 2026, Coletti acquired 5,864 shares of common stock through the exercise or conversion of derivative securities at a price of $0.
• On the same date, 1,718 shares of common stock were disposed of at $190.02 per share to cover tax liabilities or exercise prices.
• Following these transactions, Coletti directly beneficially owned 11,445 shares of common stock.
• The reported common stock holdings include 120 shares acquired on January 30, 2026, and 69 shares acquired on January 31, 2025, under the ALGN Employee Stock Purchase Plan.
• Coletti was granted 5,493 new Restricted Stock Units (RSUs) on February 20, 2026, which will vest 1/4th annually starting February 20, 2027.
• Additionally, 11,153 new Market Stock Units (MSUs) were granted on February 20, 2026, with vesting contingent on performance over a three-year period, potentially reaching 250% of the target amount.
• Several previously granted RSUs and MSUs vested on February 20, 2026, resulting in the delivery of shares: 598 RSUs (from a 2024 grant), 947 RSUs (from a 2025 grant), 291 RSUs (from a 2022 grant), 3,490 MSUs (from a 2023 grant), and 538 RSUs (from a 2023 grant).

Sentiment

Score: 6

Explanation: StockSavvy.ai views this filing as largely neutral, reflecting routine executive compensation activities. The grants of new equity awards are a positive sign of continued long-term incentives, while the dispositions are standard for tax purposes upon vesting.

Positives

• Acquisition of 5,864 shares of common stock through derivative conversion, increasing direct ownership.
• Grant of 5,493 new Restricted Stock Units (RSUs) and 11,153 new Market Stock Units (MSUs), indicating continued long-term incentive compensation.
• Vesting of various previously granted RSUs and MSUs, demonstrating the realization of prior equity compensation.

Negatives

• Disposition of 1,718 shares of common stock at $190.02 to cover tax liabilities, which reduces direct share count.

Future Outlook

The filing indicates future vesting schedules for newly granted equity awards. The 5,493 Restricted Stock Units granted on February 20, 2026, will vest 1/4th annually starting February 20, 2027. The 11,153 Market Stock Units granted on February 20, 2026, will vest, if at all, on the last day of the third year of their performance period, with a potential maximum payout of 250% of the target amount based on performance.

Industry Context

StockSavvy.ai notes that these transactions are routine for executive compensation, reflecting the typical structure of long-term incentive plans in the medical device and technology sectors. Equity awards like RSUs and MSUs are standard mechanisms used by companies like Align Technology to align executive interests with shareholder value over multi-year performance periods.

Comparison to Industry Standards

• The use of Restricted Stock Units (RSUs) and Market Stock Units (MSUs) for executive compensation is a common practice across various industries, including medical technology and consumer goods, similar to companies like Johnson & Johnson or Apple Inc.
• The vesting schedule of 1/4th annually for RSUs is a standard approach to encourage long-term retention and performance, comparable to practices at companies such as Medtronic or Stryker.
• Market Stock Units with performance-based vesting over a three-year period and a potential 250% maximum payout are typical for incentivizing executives to achieve specific financial or operational targets, aligning with best practices seen in high-growth tech companies.

Related Party Transactions

• The transactions involve the reporting person (an executive) and the issuer (Align Technology, Inc.), which are considered related parties in the context of executive compensation and stock ownership.

Stakeholder Impact

• Shareholders: The grant of new equity awards aligns executive incentives with long-term shareholder value. The disposition of shares for tax purposes is a routine event and does not indicate a change in management's confidence.

Next Steps

• 1/4th of the 5,493 Restricted Stock Units granted on February 20, 2026, will vest on February 20, 2027, with shares delivered on that date. Subsequent 1/4th portions will vest annually thereafter.
• The 11,153 Market Stock Units granted on February 20, 2026, will vest, if performance conditions are met, on the last day of the third year of the Performance Period.

Key Dates

Recommendation

This Form 4 filing details routine executive compensation activities, including the vesting of equity awards and the grant of new ones, along with associated tax-related share dispositions. Such transactions are expected and do not provide new fundamental information about the company's operational performance or strategic direction that would warrant a change in investment recommendation. Therefore, a "hold" recommendation is appropriate as the filing does not present a compelling reason to buy or sell based solely on these insider transactions.

Keywords

Align Technology, ALGN, SEC Form 4, Insider Trading, Stock Transactions, Restricted Stock Units, Market Stock Units, Equity Compensation, Executive Compensation, Julie Ann Coletti